Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.085 USD | +1.29% | -1.45% | -43.44% |
May. 07 | Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value | CI |
May. 02 | Transcript : Aurinia Pharmaceuticals Inc., Q1 2024 Earnings Call, May 02, 2024 |
Evolution of the average Target Price on Aurinia Pharmaceuticals Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Aurinia Pharmaceuticals Inc.
HC Wainwright | |
RBC Capital Markets | |
Oppenheimer | |
SVB Securities LLC | |
SVB Financial | |
Cantor Fitzgerald | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- AUPH Stock
- Consensus Aurinia Pharmaceuticals Inc.